Metabolism

OTC

VED

Calcium gluconate Velpharm  

Calcium gluconate Velpharm

OTC

VED

Active ingredient (INN)
calcium gluconate monohydrate
Composition (active ingredients)
calcium gluconate monohydrate - 500,0 mg
Фармакотерапевтическая группа
calcium phosphorus metabolism regulator
Pharmacotherapeutic group
round flat-cylindrical tablets with a facet and a risk of 500 mg
Сonditions of supply
over-the-counter
Indications

Indications

  • diseases accompanied by hypocalcemia, increased permeability of cell membranes (including blood vessels), impaired conduction of nerve impulses in muscle tissue;
  • hypoparathyroidism (latent tetany, osteoporosis), vitamin D metabolism disorders: rickets (spasmophilia, osteomalacia), hyperphosphatemia in patients with chronic renal failure;
  • increased need for calcium ions (pregnancy, period of breastfeeding, period of increased growth of the body), insufficient content of calcium ions in food, impaired metabolism (in the postmenopausal period);
  • increased excretion of calcium ions (prolonged bed rest, chronic diarrhea, secondary hypocalcemia with long-term use of diuretics and antiepileptic drugs, glucocorticosteroids);
  • poisoning with magnesium salts, oxalic and hydrofluoric acids and their soluble salts (when interacting with calcium gluconate, insoluble and non-toxic calcium oxalate and calcium fluoride are formed);
  • hyperkalemic form of paroxysmal myoplegia.
Dosage regimen

Dosage regimen

Inside, before a meal or 1-1.5 hours after ingestion (washed down with milk). Grind tablets before use.
Doses are determined by the attending physician individually, depending on the clinical picture.

Hypoparathyroidism (latent tetany, osteoporosis)

adults - 1-3 g (2-6 tablets) 2-3 times a day; children 3-4 years old - 1 g (2 tablets); 5-6 years - 1-1.5 g (2-3 tablets); 7-9 years old - 1.5-2 g (3-4 tablets); 10-14 years - 2-3 g (4-6 tablets); frequency of admission - 2-3 times a day

Impaired vitamin D metabolism: rickets (spasmophilia, osteomalacia), hyperphosphatemia in patients with chronic renal failure

adults - 1-3 g (2-6 tablets) 2-3 times a day; children 3-4 years old - 1 g (2 tablets); 5-6 years - 1-1.5 g (2-3 tablets); 7-9 years old - 1.5-2 g (3-4 tablets); 10-14 years - 2-3 g (4-6 tablets); frequency of admission - 2-3 times a day

Increased need for calcium (pregnancy, lactation, period of increased body growth), insufficient calcium in food, impaired metabolism

adults - 1-3 g (2-6 tablets) 2-3 times a day; children 3-4 years old - 1 g (2 tablets); 5-6 years - 1-1.5 g (2-3 tablets); 7-9 years old - 1.5-2 g (3-6 tablets); 10-14 years - 2-3 g (4-6 tablets); frequency of admission - 2-3 times a day

Increased calcium excretion (prolonged bed rest, chronic diarrhea, secondary hypocalcemia with long-term use of diuretics and antiepileptic drugs, glucocorticosteroids)

adults - 1-3 g (2-6 tablets) 2-3 times a day; children 3-4 years old - 1 g (2 tablets); 5-6 years - 1-1.5 g - (2-3 tablets); 7-9 years old - 1.5-2 g (3-4 tablets); 10-14 years - 2-3 g (4-6 tablets); frequency of admission - 2-3 times a day

Poisoning with magnesium salts, oxalic and fluoric acids and their soluble salts

adults - 1-3 g (2-6 tablets) 2-3 times a day; children 3-4 years old - 1 g (2 tablets); 5-6 years - 1-1.5 g (2-3 tablets); 7-9 years old - 1.5-2 g (3-4 tablets); 10-14 years - 2-3 g (4-6 tablets); frequency of admission - 2-3 times a day

Hyperkalemic form of paroxysmal myoplegia

adults - 1-3 g (2-6 tablets) 2-3 times a day; children 3-4 years old - 1 g (2 tablets); 5-6 years - 1-1.5 g (2-3 tablets); 7-9 years old - 1.5-2 g (3-4 tablets); 10-14 years - 2-3 g (4-6 tablets); frequency of admission 2-3 times a day

The duration of use for the prevention and treatment of calcium deficiency is determined by the doctor and averages from ten days to one and a half months.

Contraindications

There are contraindications, consult with a specialist before use